Analyst Ratings for BioMarin Pharmaceutical Inc. (bmrn)

bmrn Rating Summary

bmrn Price Target Summary

* Over Last 12-Mos
  |   Expand Research on bmrn
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $112.42 (+37%) * Over Last 12-Mos
Rating Score: 7.6 / 10   Percentile Rank: 84%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/29/2016 Barclays Downgrade Equalweight
(Overweight)
105.00
(125.00)
88.36 82.08 -7.11% Details
11/7/2016 Piper Jaffray Downgrade Neutral
(Overweight)
84.00
(105.00)
82.00 82.08 0.1% Details
Like BMRN Ratings? Also take a look at SRPT, SNY, VRTX, INCY

BMRN Ratings News